A light-emitting device includes a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode and including an emission layer, and an amine-containing compound represented by Formula 1, which is defined in the specification.

##STR00001##

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau.

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative dieses associated with abnormal accumulation of protein tau.

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau.

One-step cyanide-catalyzed benzoin condensations for synthesizing shape persistent cyclobenzoin macrocycles. Selected dialdehydes, and cyanide salts are reacted in aqueous solvents to form such cyclobenzoin macrocycles.

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative dieses associated with abnormal accumulation of protein tau.

One-step cyanide-catalyzed benzoin condensations for synthesizing shape persistent cyclobenzoin macrocycles. Selected dialdehydes, and cyanide salts are reacted in aqueous solvents to form such cyclobenzoin macrocycles.

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau.

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau.

An oxygen-absorbing compound has oxygen-absorbing properties and generates less odor. An oxygen-absorbing adhesive composition and a coating agent composition are produced using the oxygen-absorbing compound. The adhesive composition is used for forming an adhesive layer in a laminate for a packaging material, generates less odor, absorbs oxygen in a packaging bag or a packaging container to prevent the deterioration of a content in the packaging bag or the packaging container, and has an excellent balance among adhesion strength, the amount of generated odor and oxygen adsorption properties. The coating agent composition forms a coating layer for the surface of the laminate for a packaging material, generates less odor, and absorbs oxygen penetrating through the laminate or oxygen in a packaging bag or container. The oxygen-absorbing compound has one or two or more unsaturated five-membered rings that have a carbon-carbon double bond.